Revenue
2021
2022
2023
2024
2025
ProQR Therapeutics N.V. (PRQR)
Price$2.07Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €15.9M | €18.9M | €6.5M | €3.6M | €1.3M | — | — | — | — | — | — |
| Research & development | €44.7M | €36.4M | €25.1M | €50.9M | €42.2M | €38.1M | €46.5M | €29.5M | €31.2M | €31.9M | €23.4M |
| Operating expenses | €59.8M | €50.0M | €41.4M | €69.5M | €59.6M | €51.8M | €59.4M | €42.1M | €42.0M | €41.4M | €30.2M |
| Operating income | −€43.4M | −€30.5M | −€31.9M | −€65.2M | −€57.2M | −€42.4M | −€57.4M | −€36.3M | −€40.5M | −€39.6M | −€27.0M |
| Operating margin | −273.14% | −161.18% | −489.09% | −1,812.99% | −4,285.39% | — | — | — | — | — | — |
| EBITDA | −€40.7M | −€27.7M | −€29.3M | −€62.6M | −€54.9M | −€40.0M | −€55.4M | −€35.3M | −€39.4M | −€38.3M | −€26.5M |
| EBITDA margin | −256.15% | −146.58% | −450.51% | −1,742.85% | −4,110.94% | — | — | — | — | — | — |
| Net income | −€42.2M | −€27.8M | −€27.7M | −€64.2M | −€60.8M | −€46.6M | −€56.7M | −€37.1M | −€43.7M | −€39.1M | −€20.8M |
| Net profit margin | −265.21% | −146.86% | −425.78% | −1,786.42% | −4,554.23% | — | — | — | — | — | — |
| Basic EPSper basic share | -€0.40 | -€0.32 | -€0.35 | -€0.90 | -€0.95 | -€0.93 | -€1.38 | -€1.08 | -€1.72 | -€1.67 | -€0.89 |
| Diluted EPSper diluted share | -€0.40 | -€0.32 | -€0.35 | -€0.90 | -€0.95 | -€0.93 | -€1.38 | -€1.08 | -€1.72 | -€1.67 | -€0.89 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 9.02M |
Aberdeen Group plc | 8.93M |
Affinity Asset Advisors, LLC | 5.54M |
Privium Fund Management B.V. | 5.52M |
Ikarian Capital, LLC | 3.43M |
Woodline Partners LP | 3.28M |
HEIGHTS CAPITAL MANAGEMENT, INC | 2.76M |
MORGAN STANLEY | 1.77M |
SPHERA FUNDS MANAGEMENT LTD. | 1.76M |
Kynam Capital Management, LP | 1.57M |
DAFNA Capital Management LLC | 1.53M |
Squadron Capital Management LLC | 1.51M |
683 Capital Management, LLC | 1.39M |
CITADEL ADVISORS LLC | 1.18M |
PLATINUM INVESTMENT MANAGEMENT LTD | 1.16M |
TWO SIGMA INVESTMENTS, LP | 1.14M |
Eversept Partners, LP | 1.02M |
BOOTHBAY FUND MANAGEMENT, LLC | 948.74K |
DIADEMA PARTNERS LP | 926.02K |
Platenburg Gerardus Johannes | 824.39K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 | Filius BartDirector | BuyOrdinary Shares | 150.0K | $1.54 | $231.0K | 150.0K |